Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial.
Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A; GUARDIAN Investigators (The GUARD during Ischemia Against Necrosis). Klatte K, et al. Among authors: jessel a. J Am Coll Cardiol. 2001 Oct;38(4):1070-7. doi: 10.1016/s0735-1097(01)01481-4. J Am Coll Cardiol. 2001. PMID: 11583884 Free article.
Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial.
Gavard JA, Chaitman BR, Sakai S, Stocke K, Danchin N, Erhardt L, Gallo R, Chi E, Jessel A, Théroux P; GUARd During Ischemia Against Necrosis (GUARDIAN) Investigators. Gavard JA, et al. Among authors: jessel a. J Thorac Cardiovasc Surg. 2003 Sep;126(3):807-13. doi: 10.1016/s0022-5223(03)00735-9. J Thorac Cardiovasc Surg. 2003. PMID: 14502157 Free article.
Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study.
Boyce SW, Bartels C, Bolli R, Chaitman B, Chen JC, Chi E, Jessel A, Kereiakes D, Knight J, Thulin L, Theroux P; GUARD During Ischemia Against Necrosis (GUARDIAN) Study Investigators. Boyce SW, et al. Among authors: jessel a. J Thorac Cardiovasc Surg. 2003 Aug;126(2):420-7. doi: 10.1016/s0022-5223(03)00209-5. J Thorac Cardiovasc Surg. 2003. PMID: 12928639 Free article. Clinical Trial.
Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.
Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT, Jessel A. Théroux P, et al. Among authors: jessel a. Circulation. 2000 Dec 19;102(25):3032-8. doi: 10.1161/01.cir.102.25.3032. Circulation. 2000. PMID: 11120691 Clinical Trial.
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial.
Theroux P, Chaitman BR, Erhardt L, Jessel A, Meinertz T, Nickel WU, Schroeder JS, Tognoni G, White H, Willerson JT. Theroux P, et al. Among authors: jessel a. Curr Control Trials Cardiovasc Med. 2000;1(1):59-67. doi: 10.1186/cvm-1-1-059. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714411 Free PMC article.
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A. Flather MD, et al. Among authors: jessel a. Eur Heart J. 2000 Sep;21(17):1473-81. doi: 10.1053/euhj.1999.2005. Eur Heart J. 2000. PMID: 10952840 Clinical Trial.
31 results